CRINETICS PHARMACEUTICALS, INC.

Company

Crinetics Pharmaceuticals, Inc.

Filed

September 18, 2023

Accession Number

0000902664-23-004806

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →